ONVO News and Press, Organovo Holdings Inc. From 09/06/22

SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), an early-stage biotechnology company that is focusing on building high fidelity, 3D tissues that recapitulate key aspects of human disease, today announced that Keith Murphy, Executive Chairman, will parti...

SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), an early-stage biotechnology company that is focusing on building high fidelity, 3D tissues that recapitulate key aspects of human disease (the “Company”), today announced that its 2022 Annua...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning! Moving stocks this morning are clinical trial data, a business com...

ContraFect ( CFRX ) -19% . United Maritime ( USEA ) -14% . Organovo Holdings ( ONVO ) -9% . Revelation Biosciences ( REVB ) -9% . Melco Resorts & Entertainment ( MLCO ) -7% after Chinese regulators close Macau casinos to cu...

Seritage Growth Properties ( SRG ) +52% surges on filing prelim proxy materials for Plan of Sale. United Maritime ( USEA ) +34% as gets delivery of Japanese built vessel, secures additional financing. Insignia Systems ( ISIG ) +27% insignia System...

FTSE Russell has released a preliminary lists of companies set to join or leave the Russell Microcap Index as part of its 2022 annual reconstitution. Notable health care additions include: Inovio Pharma (INO), Bionano Genomics (BNGO), Sorrento Therapeutics (SRNE), Ocu...

SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional (3D) biology company focused on delivering scientific and medical breakthroughs using novel technologies including 3D bioprinting, today announces that it has successfully advanced its fi...

Shares of Organovo Holdings, Inc . (NASDAQ: ONVO) , an early-stage biotech company that specializes in 3D bioprinting to aid drug development, jumped 49.7% this week, according to data provided by S&P Global Market Intelligence . The stock closed at $3.12 last Friday, then o...

SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO (OTCPK: CLLKF, Nasdaq Stockholm: BICO.ST) announced they have reached agreement on a broad license for BICO and its affiliate companies to Organovo’s foundational patent portfolio in 3D bio...

Organovo (NASDAQ:ONVO) and BICO reached agreement on a broad license for BICO and its affiliate companies to Organovo’s foundational patent portfolio in 3D bioprinting. Organovo and BICO were engaged in several legal disputes regarding the patents. The companies said that under the new...